US STOCK
EHC Stock Analysis
US stocks · market data · technical indicators
Encompass Health Corporation
EHCUS stocksQuote delayed 15 min
10/26 下午10:35 updated
$125.59
+1.50+1.21%
Open
$124.10
High
$126.59
Low
$123.84
Volume
5.99萬
EHC price history
+1.68%Open
124.02
Latest
126.10
High
127.87
Low
119.06
Average
123.47
Advertisement
Financial snapshot
EHC - Encompass Health Corporation
EPS
5.98USD
Forward EPS
6.68USD
P/E
21.09x
Forward P/E
18.88x
P/B
4.80x
ROE
24.97%
ROA
9.80%
Operating margin
18.05%
Profit margin
10.01%
Revenue growth
9.60%
Earnings growth
10.80%
Dividend yield
0.68%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $1.60B | $1.59B | $1.54B | $1.48B | $1.46B |
| Gross profit | $1.53B | $1.52B | $1.48B | $1.41B | $626.90M |
| Operating income | $288.40M | $301.60M | $283.40M | $243.60M | $259.10M |
| Net income | $153.90M | $194.50M | $146.10M | $126.50M | $142.10M |
| Basic EPS | 1.55 | 1.96 | 1.45 | 1.26 | 1.41 |
| Diluted EPS | 1.54 | 1.93 | 1.43 | 1.24 | 1.39 |
Estimates vs actuals
Next earnings
2026-10-28
EPS estimate
1.36
Revenue estimate
$1.60B
Last surprise
+4.75%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-10-28 | 1.36 | Not reported | — |
| 2026-08-05 | 1.48 | 1.55 | +4.75% |
| 2026-04-30 | 1.49 | 1.60 | +7.09% |
| 2026-02-05 | 1.30 | 1.46 | +12.14% |
| 2025-10-29 | 1.19 | 1.23 | +3.20% |
| 2025-08-04 | 1.21 | 1.40 | +15.82% |
| 2025-04-24 | 1.19 | 1.37 | +15.27% |
| 2025-02-06 | 1.02 | 1.17 | +14.17% |
| 2024-10-28 | 0.94 | 1.03 | +9.29% |
| 2024-08-05 | 1.01 | 1.11 | +9.49% |
| 2024-04-24 | 0.94 | 1.12 | +19.60% |
| 2024-02-07 | 0.82 | 0.95 | +16.46% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $1.1B | 0.02% |
| BlackRock Inc. | 2024-06-30 | $776.1M | 0.02% |
| STATE STREET CORP | 2026-06-30 | $322M | 0.01% |
| CITADEL ADVISORS LLC | 2026-06-30 | $259.1M | 0.03% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $229.2M | 0.17% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $17.6M | 0.02% |
| Bridgewater Associates, LP | 2026-06-30 | $4.1M | 0.02% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$148.17
Target range
$140.00 – $155.00
Implied upside
17.50%
Strong buy
1
Buy
12
Hold
0
Sell
0
Strong sell
0
Dividends
Annual yield
0.62%
Frequency
Quarterly
Recent payouts
- 2026-10-01$0.2100
- 2026-07-01$0.1900
- 2026-04-01$0.1900
- 2026-01-02$0.1900
Advertisement